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Abstract
Three horse-derived antivenoms were tested for their ability to neu-tralize lethal, hemorrhagic, edema-forming, defibrinating and myotoxicactivities induced by the venom of Bothrops atrox from Antioquia andChocó (Colombia). The following antivenoms were used: a) polyva-lent (crotaline) antivenom produced by Instituto Clodomiro Picado(Costa Rica), b) monovalent antibothropic antivenom produced byInstituto Nacional de Salud-INS (Bogotá), and c) a new monovalentanti-B. atrox antivenom produced with the venom of B. atrox fromAntioquia and Chocó. The three antivenoms neutralized all toxicactivities tested albeit with different potencies. The new monovalentanti-B. atrox antivenom showed the highest neutralizing ability againstedema-forming and defibrinating effects of B. atrox venom (41 ± 2and 100 ± 32 µl antivenom/mg venom, respectively), suggesting thatit should be useful in the treatment of B. atrox envenomation inAntioquia and Chocó.
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Introduction
Antioquia and Chocó are located in thenorthwest region of Colombia, a zone withlarge reserves of tropical rain forest that haveallowed the development of an importantbiodiversity, including 104 snake species (1).These regions and the Amazonas have thehighest incidence of snake bites in Colom-bia, most of them caused by the abundantspecies Bothrops atrox, with a death rate of
5% and sequelae in 6% of the patients (2,3).This is mainly the result of late arrival at thehospital or, in some cases, of an insufficientantivenom supply or the high cost of lyo-philized products. The venom of B. atrox hasproteolytic, defibrinating, hemorrhagic,myotoxic, edema-forming and indirecthemolytic activities, with regional differencesin venom activities (4).These facts prompted us to produce amonovalent anti-B. atrox antivenom specific
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for the regions of Antioquia and Chocó, andto compare its neutralizing activity againsthomologous venom with two other crotalineantivenoms available in this region.
Material and Methods
Animals, venom and antivenoms
Webster white mice (18-20 g) were usedfor the in vivo experiments. The venom of B.atrox was a pool obtained from 40 speci-mens collected in Antioquia and Chocó,Colombia, lyophilized and stored at -20oCuntil the time for use. One adult horse wasimmunized at Instituto Clodomiro Picado(Costa Rica) with B. atrox venom fromAntioquia and Chocó, using the immuniza-tion protocol shown in Table 1. At the end ofthe immunization schedule, the horse wasbled and plasma was fractionated by ammo-nium sulfate precipitation (5).For comparative purposes in the neutral-ization experiments, the following two com-mercially available antivenoms were used:a) the polyvalent (crotaline) antivenom ofInstituto Clodomiro Picado (ICP), San José,Costa Rica, batch 2460294 LQ, produced inhorses by the same immunization scheduleas described above, using a mixture of equalweights of solid venoms of B. asper,  Lachesismuta and Crotalus durissus durissus from
Costa Rica and, b) the monovalent antibo-thropic antivenom of Instituto Nacional deSalud (INS), Santafé de Bogotá, batch140992, produced in horses immunized withB. atrox venom from various regions of Co-lombia. These two antivenoms were alsoproduced using similar fractionation proto-cols based on ammonium sulfate precipita-tion of globulins, without pepsin digestion(5). Phenol (0.25%) was added as a preser-vative and the antivenoms were tested be-fore their expiration dates.
Pharmacological activities of B. atrox venom
The minimum edema-forming (MED),hemorrhagic (MHD) and defibrinating(MDD) doses of B. atrox venom were deter-mined by methods described elsewhere (6-8), and modified by Gutiérrez et al. (9-11).Lethality (lethal dose 50%, LD50) was deter-mined by the Spearman-Karber method (12)using the ip route. Myonecrosis was evalu-ated by plasma creatine kinase (CK) levelsand histologically by determining themyonecrosis index as described by Gutiérrezet al. (13,14) and Lomonte et al. (15).
Neutralization assays
The neutralization assays were perfomedby incubating a constant amount of solidvenom with various dilutions of antivenom,in order to obtain several antivenom/venomratios. Incubations were carried out at 37oCfor 30 min and the mixtures were then testedin the corresponding assay systems for eachpharmacological activity. The doses of ven-om selected to test each effect were thefollowing: a) edema: 6 MED = 9 µg; b)hemorrhage: 10 MHD = 16 µg; c) defibrina-tion: 2 MDD = 2.3 µg; d) lethality: 4 LD50 =265 µg; e) myonecrosis: 50 µg. Neutralizingability is reported as effective dose 50%(ED50), defined as the µl antivenom/mg ven-om ratio that reduces by 50% the activity ofvenom alone. In the case of neutralization of
Table  1 - Im munization s che dule  for the  produc-tion of B. atrox m onovale nt and crotaline  polyva-le nt antive noms at Ins tituto Clodomiro Picado.
The  venom  was  inje cte d subcutaneous ly.
Day No. Venom dos e  (mg) Adjuvant
0 0.75 Fre undís  com ple te
10 1.5 Freundís  incomple te
20 3.0 Sodium alginate
30 9.0 Sodium alginate
40 18.0 Sodium alginate
50 30.0 Sodium alginate
60 45.0 Sodium alginate
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defibrinating activity, results are reported aseffective dose 100% (ED100), defined as theµl antivenom/mg venom ratio at which theeffect of the venom was completely neutral-ized. All experiments were repeated on threedifferent days.
Statistical analysis
Data were analyzed statistically by one-way analysis of variance (ANOVA). Whenthe values were significantly different(P<0.05), the differences between pairs ofmeans were analyzed by the Tukey test.
Results
Pharmacological activities of B. atrox venom
The lethal dose 50% of B. atrox venominjected intraperitoneally into mice was 66.2µg (95% confidence limits: 49.5-88.6). Theminimum hemorrhagic dose was 1.6 ± 0.6µg, the minimum edema-forming dose 1.5 ±0.3 µg, and the minimum defibrinating dose1.1 ± 0.3 µg. After im injection of 50 µg ofvenom, plasma CK levels increased to 664 ±116 U/ml (control mice injected with saline
solution: 60 ± 36 U/ml) and the myonecrosisindex was 1.0 (control = 0), confirming themyotoxic effect of the venom.
Neutralization of venom activities
Table 2 shows that the three antivenomsneutralized all pharmacological activities ofB. atrox venom studied, albeit with differentpotencies. Monovalent antibothropic (INS)and monovalent anti-B. atrox antivenomswere equally potent in the neutralization oflethality and hemorrhage, whereas the poly-valent (ICP) antivenom was less efficient inthe neutralization of these effects. Regard-ing edema and defibrination, the monova-lent anti-B. atrox antivenom showed the high-est neutralizing ability. No significant differ-ences were observed between the three anti-venoms concerning neutralization of myo-necrosis (Table 2).
Discussion
The parenteral administration of horse-or sheep-derived antivenoms constitutes thecornerstone in the treatment of snakebiteenvenomation (16). Since venoms present
Table  2 - Ne utralization of pharmacological activitie s  of B. atrox ve nom from Antioquia and ChocÛ by the  threeantive noms .
Ne utralization is  reported as  e ffe ctive  dos e  50%  for le thal, he morrhagic, e de ma-forming and m yonecrotice ffects  and as  e ffe ctive  dos e  100%  for the  de fibrinating e ffe ct (s ee  Mate rial and Me thods). For le thality,re s ults  are  re porte d as  m ean and 95%  confidence  lim its  (give n in pare nthes e s ). For the  othe r e ffects , re sultsare  re porte d as  me an ±  SD (N = 3). Value s  w ith diffe re nt s upe rscripts  (a,b,c) are  s ignificantly diffe re nt (P<0.05)(Tuke y te s t). +In the  ne utralization of le thality, re sults  are  also re porte d as  m g ve nom neutralized pe r m lantive nom .
Antivenom Ne utralization (µl antive nom /mg venom)
Le thality He morrhage Ede ma De fibrination Myonecros is
Monovalent anti-B. atrox 143 (96-213)a 71 ± 6 a 41 ± 2 a 100 ± 32a 110 ± 20a7.0 (4.7-10.4)+
Monovalent antibothropic (INS) 147 (100-217)a 66 ± 3 a 647 ± 176c 327 ± 133b 236 ± 109 a6.8 (4.6-10.0)+
Polyvalent (ICP) 213 (149-303)b 121 ± 18b 395 ± 13b 959 ± 36c 140 ± 22a4.7 (3.3-6.7)+
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conspicuous biochemical and pharmacolo-gical variations between and within species(17-19), it is recommended that antivenomsshould be produced in each country withvenoms obtained from snakes collected inthat particular region. Otero et al. (4) demon-strated variations in several pharmacologi-cal activities of B. atrox venoms obtainedfrom different regions of Antioquia andChocó. Thus, in order to obtain a specificantivenom against the venom of B. atroxfrom Antioquia and Chocó, a monovalentantivenom was produced and compared withtwo other crotaline antivenoms available inthese regions.Our results indicate that the three anti-venoms were effective in neutralizing themost relevant toxic effects of B. atrox ven-om. This suggests that there is a significantimmunological cross-reactivity between thevenoms of B. atrox from Antioquia andChocó, B. atrox from other regions of Co-lombia and B. asper from Costa Rica. Cross-neutralization of several antivenoms pro-duced in Latin America was demonstratedwhen they were tested against the venom ofB. atrox from Antioquia and Chocó (20).On the other hand, when the effectivedoses 50% of these antivenoms were com-pared, the monovalent anti-B. atroxantivenom produced with venoms fromAntioquia and Chocó showed the highestneutralizing ability against the venom of B.atrox from these regions.Local tissue damage (myonecrosis, hem-orrhage and edema) is one of the most typicaland dangerous consequences of B. atrox en-venomation in Colombia (2). These effectsresult in severe lesions and, in a number of
cases, in sequelae (2,3). The rapid develop-ment of these local effects makes efficientneutralization by antivenoms difficult (9-11).Thus, it is necessary to have antivenoms withhigh neutralizing capacity against the toxinsresponsible for these effects in order to reducethe local tissue damage.Our results indicate that the three anti-venoms were similarly efficient in neutraliz-ing myonecrosis, whereas monovalent anti-B. atrox antivenom had the highest neutral-izing ability against the edema-forming ef-fect. Regarding hemorrhage, monovalentanti-B. atrox and monovalent antibothropic(INS) antivenoms were more potent thanpolyvalent antivenom, although all three neu-tralized this effect at a low antivenom/ven-om ratio.In conclusion, the three antivenoms testedare efficient in neutralizing the most relevanttoxic effects induced by the venom of B.atrox from Antioquia and Chocó. Themonovalent antivenom produced with ven-oms from specimens collected in these re-gions in Colombia showed the highest neu-tralizing potency. We suggest that thisantivenom may be of high value in the treat-ment of B. atrox envenomation in Antioquiaand Chocó. A randomized clinical trial iscurrently under way in Colombia in order totest this hypothesis.
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